Elos Medtech
Elos Medtech, a prominent player in the medical technology industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1997, the company has established itself as a leader in the development and manufacturing of advanced medical devices, particularly in orthopaedics and dental applications. Elos Medtech is renowned for its innovative solutions, including precision-engineered implants and instruments that cater to the specific needs of healthcare professionals. The company’s commitment to quality and sustainability sets it apart in a competitive market, ensuring that its products meet the highest standards of safety and efficacy. With a strong market position and a reputation for excellence, Elos Medtech continues to achieve significant milestones, contributing to advancements in patient care and enhancing the overall healthcare landscape.
DitchCarbon Score
How does Elos Medtech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elos Medtech's score of 25 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elos Medtech's reported carbon emissions
In 2023, Elos Medtech reported total carbon emissions of approximately 8,600 kg CO2e. This marks an increase from 2022, when emissions were about 6,800 kg CO2e. The company has not disclosed specific data regarding Scope 1, 2, or 3 emissions, nor have they set formal reduction targets or initiatives under the Science Based Targets initiative (SBTi). Despite the lack of detailed emissions breakdowns and reduction commitments, Elos Medtech continues to monitor its greenhouse gas intensity, which was reported at approximately 0.0089 tonnes CO2e per SEK million in sales for 2023. This figure reflects the company's ongoing efforts to assess its environmental impact relative to revenue. Overall, while Elos Medtech has not established specific climate pledges or reduction targets, the company is actively tracking its emissions and greenhouse gas intensity as part of its sustainability strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elos Medtech is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
